Form 4 for SLDB Solid Biosciences Inc.
Accepted 2022-10-04 00:00:00 ET · period of report 2022-10-03 · accession 0001209191-22-052331 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-04 | 2022-10-03 | SLDB | SMITH IAN F | Dir | M - OptEx | — | +24.3K | 343.2K | +8% | — |
| D | 2022-10-04 | 2022-10-03 | SLDB | SMITH IAN F | Dir | M - OptEx | $0.00 | -24.3K | 24.3K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-03 | M | A | 24,312 | — | 343,208 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2022-10-03 | M | D | 24,312 | $0.00 | 24,312 | D | — · — to — | 24,312 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The restricted stock units were granted on January 3, 2022 and vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the award will accelerate in full. |